NCT02882841View on ClinicalTrials.gov

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients

NATerminatedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Crohn's Disease
Interventions
OTHER

Biopsies, stool and blood collection

Trial Locations (3)

02115

Children's Hospital Boston, Boston

Unknown

Hôpital Saint-Antoine, Paris

Guy's and St Thomas' NHS Foundation Trust, London

Sponsors

Lead Sponsor

Enterome
All Listed Sponsors
collaborator

Eurofins Optimed

INDUSTRY

lead

Enterome

INDUSTRY

NCT02882841 - MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients | Biotech Hunter | Biotech Hunter